| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $10,337,586 ) |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01DA063592 | Digital and Hormonal Biomarkers: Identifying Novel Targets for a Personalized Medicine Approach for Smoking Cessation in Women of Reproductive Age | 000 | 1 | NIH | 7/1/2026 | $675,774 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | U01AI181962 | Arkansas Center for Food Allergy Research (ArCOFAR) | 000 | 3 | NIH | 3/1/2026 | $300,041 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01HL173107 | Next Generation Treatments for Lymphatic Malformations | 000 | 3 | NIH | 3/25/2026 | $627,552 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01HL173537 | An Integrated Host-Microbe Gene Classifier to Predict SARS-CoV-2 and Severe Disease in Children with Respiratory Viral Coinfections | 000 | 3 | NIH | 6/5/2026 | $654,257 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | U01DA055352 | 1/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) Consortium | 000 | 6 | NIH | 7/9/2026 | $300,000 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | U01DA055352 | 1/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) Consortium | 000 | 6 | NIH | 7/9/2026 | $1,099,843 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | U01DA055352 | 1/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) Consortium | 000 | 6 | NIH | 7/9/2026 | $466,697 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01HL171034 | ENsuring ACcess to optimal Therapy in CF: ENACT study | 000 | 3 | NIH | 7/9/2026 | $569,850 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01AI179593 | Calcineurin Control over Aspergillus Fumigatus Antifungal Response Mechanisms | 000 | 3 | NIH | 6/12/2026 | $530,524 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01DK138153 | Deimplementation of Inappropriate Feeding Practices in Early Care andEducation Settings | 000 | 3 | NIH | 4/27/2026 | $611,659 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | K23HD109727 | Salivary miRNAs as Prognostic Markers of Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia in Extremely Low Gestational Age Infants | 002 | 5 | NIH | 6/30/2026 | $159,422 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | P20GM121293 | Center for Translational Pediatric Research | 001 | 10 | NIH | 7/6/2026 | $1,740,672 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01ES036986 | Perinatal PFAS Impact Children's Development: Examining the Roles of Placental Functional Multiomics and Protection by Maternal Exercise | 000 | 2 | NIH | 12/22/2025 | $656,283 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01HD117940 | Evaluating Maternal and Neonatal Pharmacokinetics of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators - The ELECTRA Pregnancy Study | 000 | 2 | NIH | 5/26/2026 | $635,230 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | UG1OD024945 | Arkansas ECHO ISPCTN Site (AREIS) | 001 | 9 | NIH | 6/19/2026 | $1 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | K99GM159200 | Understanding the Mechanisms of Muscle Catabolism after Burn Injury | 000 | 1 | NIH | 6/3/2026 | $107,307 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | K23HL181400 | ECLIPSE- Extent and CLinical Impact of Pigment in Pulse oximeter Saturation Error in ICU infants | 000 | 1 | NIH | 5/26/2026 | $184,882 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | U01AI181962 | Arkansas Center for Food Allergy Research (ArCOFAR) | 000 | 3 | NIH | 3/1/2026 | $339,987 |
| | 2026 | 2026 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01HL177528 | Partial Heart Transplantation: Clinically Relevant Aspects of Transplant Biology | 000 | 1 | NIH | 5/4/2026 | $801,261 |
| | 2026 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R21AI180334 | PKA-Dependent Autophagy Control in Aspergillus fumigatus Pathogenesis | 000 | 2 | NIH | 3/19/2026 | $0 |
| | 2026 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | K23HD109727 | Salivary miRNAs as Prognostic Markers of Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia in Extremely Low Gestational Age Infants | 000 | 4 | NIH | 12/19/2025 | $0 |
| | 2026 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | K23HL174407 | Multifactorial Asthma Determinants in Underresourced Pediatric Populations | 000 | 2 | NIH | 7/8/2026 | -$91,850 |
| | 2026 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | K23HL174407 | Multifactorial Asthma Determinants in Underresourced Pediatric Populations | 001 | 2 | NIH | 7/14/2026 | -$1 |
| | 2026 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | P20GM109096 | Center for Childhood Obesity Prevention | 001 | 10 | NIH | 5/8/2026 | $0 |
| | 2026 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | P20GM109096 | Center for Childhood Obesity Prevention | 000 | 10 | NIH | 1/29/2026 | $0 |
| | 2026 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | P20GM121293 | Center for Translational Pediatric Research | 000 | 9 | NIH | 12/19/2025 | $0 |
| | 2026 | 2024 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R21AI173759 | DNA-PKcs Regulation of LAT-Mediated Early TCR Signaling in CD4+ and CD8+ T Cells | 000 | 2 | NIH | 2/13/2026 | -$1,651 |
| | 2026 | 2024 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01AI159684 | Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients | 000 | 5 | NIH | 2/11/2026 | $0 |
| | 2026 | 2024 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R24OD037683 | Promoting Rigor and Reproducibility in Rodent Models of Metabolic Disease through Thermoneutral Housing | 000 | 1 | NIH | 12/12/2025 | -$13,977 |
| | 2026 | 2024 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | UG1OD024945 | Arkansas ECHO ISPCTN Site (AREIS) | 000 | 7 | NIH | 2/25/2026 | $0 |
| | 2026 | 2024 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | UG1OD024945 | Arkansas ECHO ISPCTN Site (AREIS) | 000 | 7 | NIH | 2/25/2026 | $0 |
| | 2026 | 2023 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R25GM141507 | Removing Barriers to Better Data Practices through Capacity, Opportunity, and Motivation | 000 | 3 | NIH | 4/8/2026 | -$16,178 |
| | 2026 | 2022 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01AI139032 | Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections | 000 | 6 | NIH | 1/22/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $16,508,702 ) (Continued on the next page) |
| | 2025 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R21AI180334 | PKA-Dependent Autophagy Control in Aspergillus fumigatus Pathogenesis | 000 | 2 | NIH | 5/21/2025 | $212,099 |
| | 2025 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01AI170385 | Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial | 006 | 4 | NIH | 9/11/2025 | $28,350 |
| | 2025 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01AI170385 | Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial | 003 | 4 | NIH | 9/11/2025 | $28,350 |
| | 2025 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01AI170385 | Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial | 002 | 4 | NIH | 9/11/2025 | $28,350 |
| | 2025 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01AI170385 | Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial | 000 | 4 | NIH | 9/9/2025 | $1,223,727 |
| | 2025 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01AI170385 | Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial | 004 | 4 | NIH | 9/11/2025 | $28,350 |
| | 2025 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01AI159684 | Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients | 001 | 6 | NIH | 9/20/2025 | $1,502,393 |
| | 2025 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | K23HL174407 | Multifactorial Asthma Determinants in Underresourced Pediatric Populations | 000 | 2 | NIH | 8/27/2025 | $168,233 |
| | 2025 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R35GM142744 | The Role of the Mitochondrion in the Metabolic Stress Response to Burn Trauma | 000 | 4 | NIH | 1/15/2025 | $41,250 |
| | 2025 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | UG1OD024945 | Arkansas ECHO ISPCTN Site (AREIS) | 001 | 8 | NIH | 8/18/2025 | $415,800 |
| | 2025 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01HL173537 | An Integrated Host-Microbe Gene Classifier to Predict SARS-CoV-2 and Severe Disease in Children with Respiratory Viral Coinfections | 000 | 2 | NIH | 3/19/2025 | $600,849 |
| | 2025 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01HL173107 | Next Generation Treatments for Lymphatic Malformations | 000 | 2 | NIH | 3/4/2025 | $576,324 |
| | 2025 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01HL173107 | Next Generation Treatments for Lymphatic Malformations | 001 | 2 | NIH | 7/17/2025 | $64,035 |
| | 2025 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01HL171034 | ENsuring ACcess to optimal Therapy in CF: ENACT study | 001 | 2 | NIH | 6/12/2025 | $592,346 |
| | 2025 | 2025 | ARKANSAS CHILDREN'S RESEARCH INSTITUTE | 13 CHILDREN'S WAY | LITTLE ROCK | AR | 72202-3500 | PULASKI | USA | R01DK138153 | Deimplementation of Inappropriate Feeding Practices in Early Care andEducation Settings | 001 | 2 | NIH | 7/10/2025 | $613,784 |
|
